Over the past 12‑18 months the Temporary Crown and Bridge Resins market has accelerated its pace of innovation and consolidation. In March 2023, GC Corp entered a strategic partnership with DentalTech Solutions to co‑develop a light‑curable resin that achieves a 30 % reduction in setting time, a move aimed at high‑volume dental labs. July 2023 saw the acquisition of ResinFlex by 3M Oral Care, expanding the latter’s portfolio of provisional materials and granting access to ResinFlex’s patented nano‑filled matrix technology. Early 2024, Kuraray Dental launched its next‑generation “QuickSet Pro” line, featuring a dual‑cure system that integrates antimicrobial agents, positioning the product for the growing demand for infection‑control solutions. Regulatory shifts in the EU, effective May 2024, introduced stricter biocompatibility testing for temporary prosthetic materials, prompting manufacturers to accelerate clinical validation programs. Meanwhile, a $45 million Series B round led by HealthVentures enabled ProTemp Labs to double its production capacity in Asia, reflecting rising enterprise adoption of digital workflow‑compatible resins. These developments collectively shape the Temporary Crown and Bridge Resins industry trends toward faster, safer, and more integrated provisional solutions.